This podcast episode covers updates from various biomedical companies, including Genascence Corporation receiving FDA designation for a gene therapy targeting knee osteoarthritis, NRx Pharmaceuticals expanding its mental health clinics and advancing NMDA-based therapies, Lantern Pharma utilizing AI for precision oncology drug development, and more. Exciting developments in areas such as regenerative medicine, mental health therapeutics, oncology drug discovery, and viral infection treatments are highlighted, showcasing the diverse range of advancements in the biomedical field.
